Literature DB >> 10663713

Evaluation of congenital heart disease by magnetic resonance imaging.

A de Roos1, A A Roest.   

Abstract

Magnetic resonance imaging has proven to be useful in the assessment of patients with complex congenital heart disease and in the post-surgical follow-up of patients with corrected congenital heart disease. A thorough understanding of the congenital cardiac malformations that can be encountered is needed and the use of the sequential segmental analysis helps to standardize the evaluation and diagnosis of (complex) congenital heart disease. After surgical correction of congenital heart defects, patients must be followed over extended periods of time, because morphological and functional abnormalities may still be present or may develop. The use of echocardiography may be hampered in these patients as scar tissue and thorax deformities limit the acoustic window. Magnetic resonance imaging has proven to be advantageous in the follow-up of these post-surgical patients and with the use of several different techniques the morphological as well as functional abnormalities can be evaluated and followed over time.

Entities:  

Mesh:

Year:  2000        PMID: 10663713     DOI: 10.1007/s003300050002

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  10 in total

Review 1.  When to order cardiovascular magnetic resonance in adults with congenital heart disease.

Authors:  Sonya V Babu-Narayan; Philip J Kilner; Michael A Gatzoulis
Journal:  Curr Cardiol Rep       Date:  2003-07       Impact factor: 2.931

2.  Real-time color-flow CMR in adults with congenital heart disease.

Authors:  Erasmo de la Pena; Patricia K Nguyen; Krishna S Nayak; Phillip C Yang; David N Rosenthal; Bob S Hu; John M Pauly; Michael V McConnell
Journal:  J Cardiovasc Magn Reson       Date:  2006       Impact factor: 5.364

Review 3.  The right ventricle in congenital heart disease.

Authors:  P A Davlouros; K Niwa; G Webb; M A Gatzoulis
Journal:  Heart       Date:  2006-04       Impact factor: 5.994

4.  [Clinical indications for the use of cardiac MRI. By the SIRM Study Group on Cardiac Imaging].

Authors:  E Di Cesare; F Cademartiri; I Carbone; A Carriero; M Centonze; F De Cobelli; R De Rosa; P Di Renzi; A Esposito; R Faletti; R Fattori; M Francone; A Giovagnoni; L La Grutta; G Ligabue; L Lovato; R Marano; M Midiri; A Romagnoli; V Russo; F Sardanelli; L Natale; J Bogaert; A De Roos
Journal:  Radiol Med       Date:  2012-11-26       Impact factor: 3.469

Review 5.  Congenitally corrected transposition of the great arteries in an 83-year-old asymptomatic patient: description and literature review.

Authors:  Angelo Placci; Luigi Lovato; Marco Bonvicini
Journal:  BMJ Case Rep       Date:  2014-10-21

Review 6.  MR imaging of aortic coarctation.

Authors:  F Secchi; A Iozzelli; G D E Papini; A Aliprandi; G Di Leo; F Sardanelli
Journal:  Radiol Med       Date:  2009-05-14       Impact factor: 3.469

7.  Hemodynamic and electrocardiographic effects of early pulmonary valve replacement in pediatric patients after transannular complete repair of tetralogy of Fallot.

Authors:  G Kleinveld; R W Joyner; D Sallee; K R Kanter; W J Parks
Journal:  Pediatr Cardiol       Date:  2006 May-Jun       Impact factor: 1.838

8.  Role and effectiveness of cardiovascular magnetic resonance in the diagnosis, preoperative evaluation and follow-up of patients with congenital heart diseases.

Authors:  L Lovato; A Giardini; C La Palombara; V Russo; V Gostoli; G Gargiulo; F M Picchio; R Fattori
Journal:  Radiol Med       Date:  2007-07-23       Impact factor: 6.313

Review 9.  Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support.

Authors:  Tal Geva
Journal:  J Cardiovasc Magn Reson       Date:  2011-01-20       Impact factor: 5.364

10.  N-terminal pro-brain natriuretic peptide as a marker in follow-up patients with tetralogy of Fallot after total correction.

Authors:  A Khositseth; J Manop; P Khowsathit; S Siripornpitak; R Pornkul; P Lolekha; S Attanawanich
Journal:  Pediatr Cardiol       Date:  2007-06-29       Impact factor: 1.838

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.